Cargando…

Place of the (18)F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)

Objective: To explore the diagnostic contribution of the (18)F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to pinpoint its place in the diagnostic decision tree in a real-life setting, and to identify the factors associated with a diagnostic (18)F-FDG-PET/CT....

Descripción completa

Detalles Bibliográficos
Autores principales: Letertre, Simon, Fesler, Pierre, Zerkowski, Laetitia, Picot, Marie-Christine, Ribstein, Jean, Guilpain, Philippe, Le Moing, Vincent, Mariano-Goulart, Denis, Roubille, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432230/
https://www.ncbi.nlm.nih.gov/pubmed/34501277
http://dx.doi.org/10.3390/jcm10173831
Descripción
Sumario:Objective: To explore the diagnostic contribution of the (18)F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to pinpoint its place in the diagnostic decision tree in a real-life setting, and to identify the factors associated with a diagnostic (18)F-FDG-PET/CT. Method: All adult patients (aged ≥ 18 years) with a diagnosis of classical FUO who underwent an (18)F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017 were included. True positive (18)F-FDG-PET/CT, which evidenced a specific disease causing FUO, were considered to be contributive. Results: Forty-four patients with FUO have been included (20 males, 24 females; mean age 57.5 ± 17.1 years). Diagnoses were obtained in 31 patients (70.5%), of whom 17 (38.6%) had non-infectious inflammatory diseases, 9 had infections (20.5%), and 3 had malignancies (6.8%). (18)F-FDG-PET/CT was helpful for making a final diagnosis (true positive) in 43.6% of all patients. Sensitivity and specificity levels were 85% and 37%, respectively. A total of 135 investigations were performed before (18)F-FDG-PET/CT, mostly CT scans (93.2%) and echocardiography (59.1%), and 108 after (18)F-FDG-PET/CT, mostly biopsies (including the biopsy of a temporal artery) (25%) and MRIs (34%). In multivariate analysis, the hemoglobin level was significantly associated with a helpful (18)F-FDG-PET/CT (p = 0.019, OR 0.41; 95% CI (0.20–0.87)), while the CRP level was not associated with a contributive (18)F-FDG-PET/CT. Conclusion: (18)F-FDG-PET/CT may be proposed as a routine initial non-invasive procedure in the diagnostic workup of FUO, especially in anemic patients who could be more likely to benefit from (18)F-FDG-PET/CT.